Literature DB >> 24616040

Coxsackievirus B1 reveals strain specific differences in plasmacytoid dendritic cell mediated immunogenicity.

Sanna Hämäläinen1, Noora Nurminen, Helena Ahlfors, Sami Oikarinen, Amir-Babak Sioofy-Khojine, Gun Frisk, M Steven Oberste, Riitta Lahesmaa, Marko Pesu, Heikki Hyöty.   

Abstract

Enterovirus infections are usually mild but can also cause severe illnesses and play a role in chronic diseases, such as cardiomyopathies and type 1 diabetes. Host response to the invading virus can markedly modulate the course of the infection, and this response varies between individuals due to the polymorphism of immune response genes. However, it is currently not known if virus strains also differ in their ability to stimulate the host immune system. Coxsackievirus B1 (CBV1) causes severe epidemics in young infants and it has recently been connected with type 1 diabetes in seroepidemiological studies. This study evaluated the ability of different field isolates of CBV1 to induce innate immune responses in PBMCs. CBV1 strains differed markedly in their capacity to induce innate immune responses. Out of the 18 tested CBV1 strains two induced exceptionally strong alpha interferon (IFN-α) response in PBMC cultures. The responding cell type was found to be the plasmacytoid dendritic cell. Such a strong innate immune response was accompanied by an up-regulation of several other immune response genes and secretion of cytokines, which modulate inflammation, and adaptive immune responses. These results suggest that enterovirus-induced immune activation depends on the virus strain. It is possible that the immunotype of the virus modulates the course of the infection and plays a role in the pathogenesis of chronic immune-mediated enterovirus diseases.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  coxsackievirus B1 (CBV1); innate immunity; interferon-alpha (IFN-α); pDC

Mesh:

Substances:

Year:  2014        PMID: 24616040     DOI: 10.1002/jmv.23903

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.

Authors:  Amir-Babak Sioofy-Khojine; Jussi Lehtonen; Noora Nurminen; Olli H Laitinen; Sami Oikarinen; Heini Huhtala; Outi Pakkanen; Tanja Ruokoranta; Minna M Hankaniemi; Jorma Toppari; Mari Vähä-Mäkilä; Jorma Ilonen; Riitta Veijola; Mikael Knip; Heikki Hyöty
Journal:  Diabetologia       Date:  2018-02-05       Impact factor: 10.122

Review 2.  Lessons from the mouse: potential contribution of bystander lymphocyte activation by viruses to human type 1 diabetes.

Authors:  Jessica A Pane; Barbara S Coulson
Journal:  Diabetologia       Date:  2015-03-21       Impact factor: 10.122

Review 3.  Enteroviruses and Type 1 Diabetes: Multiple Mechanisms and Factors?

Authors:  Richard E Lloyd; Manasi Tamhankar; Åke Lernmark
Journal:  Annu Rev Med       Date:  2021-11-18       Impact factor: 16.048

4.  Metagenomics of the faecal virome indicate a cumulative effect of enterovirus and gluten amount on the risk of coeliac disease autoimmunity in genetically at risk children: the TEDDY study.

Authors:  Katri Lindfors; Jake Lin; Hye-Seung Lee; Heikki Hyöty; Matti Nykter; Kalle Kurppa; Edwin Liu; Sibylle Koletzko; Marian Rewers; William Hagopian; Jorma Toppari; Annette-Gabriele Ziegler; Beena Akolkar; Jeffrey P Krischer; Joseph F Petrosino; Richard E Lloyd; Daniel Agardh
Journal:  Gut       Date:  2019-11-19       Impact factor: 31.793

5.  A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates.

Authors:  V M Stone; M M Hankaniemi; O H Laitinen; A B Sioofy-Khojine; A Lin; I M Diaz Lozano; M A Mazur; V Marjomäki; K Loré; H Hyöty; V P Hytönen; M Flodström-Tullberg
Journal:  Sci Adv       Date:  2020-05-06       Impact factor: 14.136

6.  Coxsackievirus B Persistence Modifies the Proteome and the Secretome of Pancreatic Ductal Cells.

Authors:  Niina Lietzén; Karoliina Hirvonen; Anni Honkimaa; Tanja Buchacher; Jutta E Laiho; Sami Oikarinen; Magdalena A Mazur; Malin Flodström-Tullberg; Eric Dufour; Amir-Babak Sioofy-Khojine; Heikki Hyöty; Riitta Lahesmaa
Journal:  iScience       Date:  2019-07-29

7.  Persistent coxsackievirus B1 infection triggers extensive changes in the transcriptome of human pancreatic ductal cells.

Authors:  Tanja Buchacher; Anni Honkimaa; Tommi Välikangas; Niina Lietzén; M Karoliina Hirvonen; Jutta E Laiho; Amir-Babak Sioofy-Khojine; Eeva-Liisa Eskelinen; Heikki Hyöty; Laura L Elo; Riitta Lahesmaa
Journal:  iScience       Date:  2021-12-18

8.  Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect.

Authors:  Virginia M Stone; Marta Butrym; Minna M Hankaniemi; Amir-Babak Sioofy-Khojine; Vesa P Hytönen; Heikki Hyöty; Malin Flodström-Tullberg
Journal:  Diabetes       Date:  2021-09-08       Impact factor: 9.461

9.  Pancreas Whole Tissue Transcriptomics Highlights the Role of the Exocrine Pancreas in Patients With Recently Diagnosed Type 1 Diabetes.

Authors:  Tommi Välikangas; Niina Lietzén; Maria K Jaakkola; Lars Krogvold; Morten C Eike; Henna Kallionpää; Soile Tuomela; Clayton Mathews; Ivan C Gerling; Sami Oikarinen; Heikki Hyöty; Knut Dahl-Jorgensen; Laura L Elo; Riitta Lahesmaa
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-13       Impact factor: 6.055

10.  Enterovirus-associated changes in blood transcriptomic profiles of children with genetic susceptibility to type 1 diabetes.

Authors:  Niina Lietzen; Le T T An; Maria K Jaakkola; Henna Kallionpää; Sami Oikarinen; Juha Mykkänen; Mikael Knip; Riitta Veijola; Jorma Ilonen; Jorma Toppari; Heikki Hyöty; Riitta Lahesmaa; Laura L Elo
Journal:  Diabetologia       Date:  2017-11-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.